In all, our data indicated that FMNL2 may promote CDK4/CyclinD1 kinase activity and cell proliferation through inhibition of p27 nuclear localization and p27 protein stability in human breast cancer cells. This evidence concerns the gene FMNL2 and breast carcinoma.